Mechanical circulatory support of the critically ill child awaiting heart transplantation

Avihu Z Gazit1, Sanjiv K Gandhi, Charles C Canter

  • 1Division of Pediatric Critical Care, Saint Louis Children's Hospital, Washington University School of Medicine, St Louis, Mo., USA.

Insights

Pediatric mechanical circulatory support devices aid children with heart failure awaiting transplants. This review examines current devices and outcomes, including the Berlin Heart, to improve survival rates.

Area of Science:

  • Pediatric cardiology
  • Mechanical circulatory support
  • Biomedical engineering

Background:

  • Many children awaiting heart transplants require intensive support, including mechanical ventilation and extracorporeal membrane oxygenation (ECMO).
  • Limited organ availability leads to poor survival rates for these critically ill children.
  • Mechanical circulatory support (MCS) is a rapidly advancing field for pediatric heart failure.

Purpose of the Study:

  • To review international experiences with pediatric MCS.
  • To summarize institutional experience with the Berlin Heart device since 2005.
  • To compare indications, support duration, and outcomes of different MCS modalities in children.

Main Methods:

  • Review of international data on pediatric mechanical circulatory support.
  • Analysis of institutional experience with the Berlin Heart ventricular assist device.
  • Comparative analysis of various MCS devices, including ECMO, VADs, and the Berlin Heart.

Main Results:

  • The study reviews current MCS devices available for children, such as ECMO, VADs, and the Berlin Heart.
  • It highlights ongoing development of new pediatric VADs supported by the National Heart, Lung, and Blood Institute.
  • The paper compares outcomes based on indications, duration of support, and specific devices used.

Conclusions:

  • Mechanical circulatory support offers a vital option for children with end-stage heart failure.
  • Continued development and comparative analysis of devices like the Berlin Heart are crucial for improving outcomes.
  • Further research and clinical trials are anticipated with the emergence of new pediatric MCS technologies.